Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Phase I Clinical Study of CD19-Targeted CAR-NK Cell Therapy for Moderate to Severe Active Systemic Lupus Erythematosus in China

NCT07358988 is registered in ClinicalTrials.gov with Ruitherapeutics Co., LTD as lead sponsor.

NCT NCT07358988
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07358988 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Phase I Clinical Study of CD19-Targeted CAR-NK Cell Therapy for Moderate to Severe Active Systemic Lupus Erythematosus in China
Lead sponsor
Ruitherapeutics Co., LTD
Phase
Phase 1
Overall status
Not yet recruiting
Start date
January 31, 2026
Completion date
July 31, 2027
Enrollment
36 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erthematosus (sle)